Trends in the risks of melanoma as a second primary cancer among cancer patients in the Netherlands, 1989-2008

Lifang Liu; Isabelle Soerjomataram; Tamar Nijsten; M van der Aa; R van der Leest; Jan Willem Coebergh; Erhard Vries

doi:10.1097/CMR.0b013e32835f28d8

Trends in the risks of melanoma as a second primary cancer among cancer patients in the Netherlands, 1989-2008

Lifang Liu, Isabelle Soerjomataram, Tamar Nijsten, M van der Aa, R van der Leest, Jan Willem Coebergh, Erhard Vries

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	206-212
Number of pages	7
Journal	Melanoma Research
Volume	23
Issue number	3
DOIs	https://doi.org/10.1097/CMR.0b013e32835f28d8
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/CMR.0b013e32835f28d8

http://hdl.handle.net/1765/40054

Cite this

@article{eacefa05151b4914b81b8f7989088013,

title = "Trends in the risks of melanoma as a second primary cancer among cancer patients in the Netherlands, 1989-2008",

author = "Lifang Liu and Isabelle Soerjomataram and Tamar Nijsten and {van der Aa}, M and {van der Leest}, R and Coebergh, {Jan Willem} and Erhard Vries",

year = "2013",

doi = "10.1097/CMR.0b013e32835f28d8",

language = "Undefined/Unknown",

volume = "23",

pages = "206--212",

journal = "Melanoma Research",

issn = "0960-8931",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - Trends in the risks of melanoma as a second primary cancer among cancer patients in the Netherlands, 1989-2008

AU - Liu, Lifang

AU - Soerjomataram, Isabelle

AU - Nijsten, Tamar

AU - van der Aa, M

AU - van der Leest, R

AU - Coebergh, Jan Willem

AU - Vries, Erhard

PY - 2013

Y1 - 2013

U2 - 10.1097/CMR.0b013e32835f28d8

DO - 10.1097/CMR.0b013e32835f28d8

M3 - Article

SN - 0960-8931

VL - 23

SP - 206

EP - 212

JO - Melanoma Research

JF - Melanoma Research

IS - 3

ER -